Historical shareholding details of Citadel Advisors Llc holdings in Neurocrine Biosciences, Inc. (NBIX)

Monthly changes of Citadel Advisors Llc shareholding in Neurocrine Biosciences, Inc. over the previous months

Month Name Total no. shares held Percent Holding
Dec 31, 2024 Citadel Advisors Llc 2,538,109 2.57%
Sep 30, 2024 Citadel Advisors Llc 1,764,590 1.78%
Jun 30, 2024 Citadel Advisors Llc 740,939 0.73%
Sep 30, 2023 Citadel Advisors Llc 736,207 0.73%
Jun 30, 2023 Citadel Advisors Llc 1,306,273 1.34%
Mar 31, 2023 Citadel Advisors Llc 474,392 0.49%

View all ownership details of Neurocrine Biosciences, Inc.